Piribedil for restless legs syndrome: A pilot study

Movement Disorders

Volumn 16, Issue 3, 2001, Pages 579-581

  Evidente, Virgilio Gerald H ^a  

^a Institute of Urology   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; DOMPERIDONE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; LEVODOPA; PIRIBEDIL; TRIVASTAL RETARD; ZOLPIDEM;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART PALPITATION; HUMAN; MALE; MENTAL DEFICIENCY; NAUSEA AND VOMITING; NEUROPATHY; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; SOMNOLENCE; THORAX PAIN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PIRIBEDIL; RECEPTORS, DOPAMINE D2; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 0035353732     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1104     Document Type: Article

References (9)

1. Walters AS. The International Restless Legs Syndrome Study Group: toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-642.
2. Evidente VGH, Adler CH. How to help patients with restless legs syndrome: discerning the indescribable and relaxing the restless. Postgrad Med 1999;105:59-74.
3. Rondot P, Ziegler M. Activity and acceptability of Trivastal in Parkinson's disease: a multicentre study. J Neurol 1992;239:528-534.
4. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;23:200-203.
5. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999;52:944-950.
6. Montplaisir J, Nicolas A, Denesle R. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-943.
7. Ondo W. Ropinirole for restless legs syndrome. Mov Disord 1999; 14:138-140.
8. Evidente VGH, Adler CH, Caviness JN, Hentz JG, Gwinn-Hardy K. Amantadine is beneficial in restless legs syndrome. Mov Disord 2000;15:324-327.
9. Reuter I, Ellis CM, Chaudhuri RK. Nocturnal subcutaneous infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 1999;100:163-167.